Advanced Microelectrode Arrays: Every Cell Counts.
MaxWell Biosystems provides the most advanced microelectrode arrays for cardiac and neuronal cell assays to accelerate drug discovery and development.
Our system MaxOne consists of an integrated sensor chip, acquisition hardware and software. It enables long-term monitoring of thousands of cells simultaneously for applications in safety pharmacology, research, personalized medicine and preclinical drug discovery. It features 26,400 electrodes, 1024 low-noise readout channels, and 32 stimulation channels.